SCOPUS 정보 검색 플랫폼

Volumn 129, Issue 13, 2014, Pages

Letter by chyrchel et al regarding article, "unexpected effect of proton pump inhibitors: Elevation of the cardiovascular risk factor asymmetric dimethylarginine"

(3) Chyrchel, Bernadeta a Chyrchel, Michał a Surdacki, Andrzej a

a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; CLOPIDOGREL; CYTOCHROME P450 2C19; DIMETHYLARGININASE; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; OMEPRAZOLE; PROTON PUMP INHIBITOR;

BLOOD SAMPLING; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DRUG ANTAGONISM; DRUG EFFECT; ENZYME INHIBITION; HUMAN; LETTER; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

ANIMALS; ARGININE; CARDIOVASCULAR DISEASES; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; PROTON PUMP INHIBITORS;

EID: 84897420218 PISSN: 00097322 EISSN: 15244539 Source Type: Journal
DOI: 10.1161/CIRCULATIONAHA.113.006284 Document Type: Letter

Times cited : (1)

References (5)

1
- 84882810068
- Unexpected effect of proton pump inhibitors: Elevation of the cardiovascular risk factor asymmetric dimethylarginine
- Ghebremariam YT, LePendu P, Lee JC, Erlanson DA, Slaviero A, Shah NH, Leiper J, Cooke JP. Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine. Circulation. 2013;128:845-853.
- (2013) Circulation , vol.128 , pp. 845-853
- Ghebremariam, Y.T.¹ Lependu, P.² Lee, J.C.³ Erlanson, D.A.⁴ Slaviero, A.⁵ Shah, N.H.⁶ Leiper, J.⁷ Cooke, J.P.⁸

2
- 73849084548
- Proton pump inhibitor and clopidogrel interaction: Fact or fiction
- Laine L, Hennekens C. Proton pump inhibitor and clopidogrel interaction: fact or fiction Am J Gastroenterol. 2010;105:34-41.
- (2010) Am J Gastroenterol , vol.105 , pp. 34-41
- Laine, L.¹ Hennekens, C.²

3
- 79955936075
- Separate dosing of clopidogrel and omeprazole may improve platelet inhibition on dual antiplatelet therapy
- Chyrchel B, Surdacki A, Chyrchel M, Dudek D, Dubiel JS. Separate dosing of clopidogrel and omeprazole may improve platelet inhibition on dual antiplatelet therapy. Int J Cardiol. 2011;149:124-125.
- (2011) Int J Cardiol , vol.149 , pp. 124-125
- Chyrchel, B.¹ Surdacki, A.² Chyrchel, M.³ Dudek, D.⁴ Dubiel, J.S.⁵

4
- 84884617086
- Blockade of the purinergic P2Y12 receptor greatly increases the platelet inhibitory actions of nitric oxide
- Kirkby NS, Lundberg MH, Chan MV, Vojnovic I, Solomon AB, Emerson M, Mitchell JA, Warner TD. Blockade of the purinergic P2Y12 receptor greatly increases the platelet inhibitory actions of nitric oxide. Proc Natl Acad Sci USA. 2013;110:15782-15787.
- (2013) Proc Natl Acad Sci USA , vol.110 , pp. 15782-15787
- Kirkby, N.S.¹ Lundberg, M.H.² Chan, M.V.³ Vojnovic, I.⁴ Solomon, A.B.⁵ Emerson, M.⁶ Mitchell, J.A.⁷ Warner, T.D.⁸

5
- 84857992585
- Association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor: Insights from the platelet inhibition and patient outcomes trial
- Goodman SG, Clare R, Pieper KS, Nicolau JC, Storey RF, Cantor WJ, Mahaffey KW, Angiolillo DJ, Husted S, Cannon CP, James SK, Kilhamn J, Steg PG, Harrington RA, Wallentin L. Association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor: insights from the platelet inhibition and patient outcomes trial. Circulation. 2012;125:978-986.
- (2012) Circulation , vol.125 , pp. 978-986
- Goodman, S.G.¹ Clare, R.² Pieper, K.S.³ Nicolau, J.C.⁴ Storey, R.F.⁵ Cantor, W.J.⁶ Mahaffey, K.W.⁷ Angiolillo, D.J.⁸ Husted, S.⁹ Cannon, C.P.¹⁰ James, S.K.¹¹ Kilhamn, J.¹² Steg, P.G.¹³ Harrington, R.A.¹⁴ Wallentin, L.¹⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.